From: Ari Belenkiy <[log in to unmask]> Date: Sat, 19 Oct 2013 21:43:11 -0700 >> Last year researchers at one biotech firm, Amgen, found they could reproduce just six of 53 “landmark” studies in cancer research. Earlier, a group at Bayer, a drug company, managed to repeat just a quarter of 67 similarly important papers. Does anyone know the details of these results? Ari Belenkiy SFU Canada On Sat, Oct 19, 2013 at 5:56 AM, LIBLICENSE <[log in to unmask]> wrote: > > From: Ann Shumelda Okerson <[log in to unmask]> > Date: Sat, 19 Oct 2013 08:53:42 -0400 > > Of possible interest: > > http://www.economist.com/news/leaders/21588069-scientific-research-has-changed-world-now-it-needs-change-itself-how-science-goes-wrong > > Editorial and linked article on limits of peer review, > irreproducibility of surprisingly large proportion of published > articles -- more fallout from the Bohannon sting? The article notes > that he submitted to lower-tier journals; doesn't make the open access > correlation.